novel
microarray
construct
dna
pcr
product
probe
target
speci
specif
function
gene
nine
clinic
signific
respiratori
pathogen
includ
gramposit
organ
streptococcu
pneumonia
streptococcu
pyogen
gramneg
organ
chlamydia
pneumonia
coxiella
burnetii
haemophilu
spp
legionella
pneumophila
moraxella
catarrhali
pseudomona
aeruginosa
well
atyp
bacterium
mycoplasma
pneumonia
proofofconcept
evalu
develop
microarray
microarray
compar
realtim
pcr
sputum
specimen
copd
patient
sampl
posit
bacteri
speci
realtim
pcr
also
posit
bacteri
speci
use
microarray
studi
show
microarray
use
pcr
probe
potenti
use
method
monitor
popul
bacteria
respiratori
specimen
tailor
specif
clinic
need
respiratori
infect
particular
patient
popul
includ
patient
cystic
fibrosi
bronchiectasi
dna
microarray
prove
use
studi
bacteri
gene
express
use
microbi
diagnost
date
larg
focus
detect
antimicrobi
resist
epidemiolog
investig
bryant
et
al
chizhikov
et
al
grimm
et
al
hakenbeck
et
al
recent
studi
utilis
potenti
simultan
detect
unlimit
number
pathogen
diagnos
infect
rang
site
one
studi
focus
rapid
diagnosi
bacteraemia
univers
amplif
ribosom
dna
rdna
follow
hybridis
oligonucleotid
array
anthoni
et
al
found
rapid
identif
discrimin
bacteria
could
achiev
ad
oligonucleotid
panel
without
increas
significantli
complex
cost
could
continu
extend
accuraci
rang
discriminatori
power
assay
similar
conclus
found
anoth
studi
look
dna
array
detect
bacteri
pathogen
environment
sampl
call
et
al
wang
et
al
wang
et
al
investig
intestin
bacteria
human
faecal
sampl
use
rdna
pcr
oligonucleotid
microarray
sensit
array
assay
compar
classic
cultur
chizhikov
et
al
develop
microarray
target
sequenc
six
gene
encod
bacteri
antigen
determin
virul
factor
detect
enter
pathogen
salmonella
spp
shigella
spp
escherichia
coli
specif
superior
cultur
array
identif
reli
complementari
hybridis
oligonucleotid
rather
agaros
gel
analysi
base
size
pcr
product
microarray
investig
respiratori
tract
infect
focus
mainli
viral
pathogen
middl
ear
infect
mycobacterium
tuberculosi
diagnost
confirm
well
antibiot
resist
grimm
et
al
li
et
al
roth
et
al
respiratori
diseas
includ
chronic
pulmonari
diseas
copd
respons
signific
proport
seriou
morbid
mortal
worldwid
copd
embrac
number
differ
patholog
process
includ
chronic
bronchiti
chronic
bronchiol
emphysema
reid
sallenav
chronic
progress
cours
copd
often
aggrav
short
period
increas
symptom
miravitl
et
al
respiratori
tract
infect
common
caus
copd
exacerb
soto
varkey
gener
nontyp
haemophilu
influenza
streptococcu
pneumonia
lesser
extent
moraxella
catarrhali
frequent
isol
speci
cultur
exacerb
miravitl
studi
shown
exacerb
patient
sever
copd
like
associ
gramneg
organ
soler
et
al
bacteria
legionella
pneumophila
also
document
copd
lieberman
et
al
routin
clinic
microbiolog
reli
larg
cultur
number
limit
particular
lack
sensit
delay
detect
significantli
impact
treatment
manag
patient
also
limit
understand
develop
progress
respiratori
tract
infect
molecular
techniqu
hold
potenti
improv
speed
sensit
laboratori
diagnosi
respiratori
infect
curran
et
al
clinic
infect
may
caus
multipl
pathogen
therefor
altern
approach
need
allow
simultan
detect
rang
organ
within
short
time
frame
describ
design
evalu
novel
microarray
use
speci
specif
function
gene
probe
simultan
detect
multipl
bacteri
pathogen
involv
copd
microarray
result
compar
realtim
quantit
pcr
copd
sputum
sampl
util
practic
approach
discuss
american
type
cultur
collect
atcc
nation
cultur
type
collect
nctc
clinic
bacteri
strain
grown
appropri
condit
use
gener
pcr
probe
check
cross
reactiv
tabl
prepar
pcr
product
microarray
probe
pcr
reaction
use
gener
pcr
product
probe
high
titr
plasmid
prepar
function
gene
primer
bacteri
speci
use
tabl
describ
previous
except
pcr
cycl
use
curran
et
al
pcr
product
purifi
use
qiaquick
purif
kit
qiagen
pool
uk
accord
manufactur
instruct
confirm
gel
electrophoresi
dna
elut
nucleas
free
water
promega
southampton
uk
puriti
dna
concentr
assess
uv
spectrometri
pcr
product
dri
eppendorf
concentr
eppendorf
hamburg
germani
reconstitut
nexterion
spot
buffer
schott
jena
germani
concentr
mgml
use
probe
spot
dna
microarray
print
array
carri
use
biorobot
microgrid
ii
ta
robot
printer
fit
four
microspot
k
quill
pin
genom
solut
cheshir
uk
print
onto
epoxyco
nexterion
e
glass
slide
schott
jena
germani
rel
humid
probe
print
time
per
array
array
duplic
slide
addit
follow
control
spot
print
time
per
array
print
amino
modifi
label
random
land
light
buffer
control
synthet
set
mer
oligonucleotid
oligoa
oligob
use
gener
refer
signal
standard
sampl
signal
alig
technolog
ltd
cheshir
uk
oligoa
amino
link
oligo
mix
everi
probe
prior
print
oligob
label
refer
dna
ad
hybridis
mix
hybridis
oligoa
everi
spot
number
addit
oligonucleotid
probe
design
target
viral
gene
also
includ
assess
nonspecif
hybridis
includ
probe
detect
influenza
b
rsv
coronaviru
parainfluenza
viru
metapneumoviru
print
microarray
slide
incub
humid
chamber
room
temperatur
min
follow
slide
bake
min
store
dark
dri
dust
free
box
requir
immedi
prior
hybridis
slide
process
remov
unbound
probe
molecul
buffer
substanc
prevent
interfer
subsequ
hybridis
experi
involv
agit
slide
follow
solut
triton
min
room
temperatur
rt
two
wash
mm
hcl
min
rt
mm
hcl
min
rt
mm
kcl
min
rt
deionis
h
min
deionis
h
min
rt
slide
block
mm
ethanolamin
sigma
dorset
uk
sd
ad
freshli
use
tri
ph
min
everi
five
slide
least
ml
block
solut
use
slide
rins
deionis
h
room
temperatur
min
dri
oilfre
air
stream
avoid
water
stain
surfac
slide
use
immedi
hybridis
indirect
incorpor
use
amino
allyldutp
aadutp
use
label
target
dna
pcr
done
triplic
potenti
bacteri
speci
use
primer
label
tabl
reaction
mixtur
contain
pcr
reaction
buffer
promega
southampton
uk
datp
dctp
dgtp
dttp
promega
southampton
uk
aadutp
sigmaaldrich
dorset
uk
mm
mgcl
promega
southampton
uk
primer
u
taq
dna
polymeras
promega
southampton
uk
extract
sampl
dna
ad
reaction
hot
start
pcr
cycl
condit
follow
initi
denatur
min
follow
cycl
final
extens
step
min
posit
neg
control
includ
pcr
run
three
pcr
reaction
speci
combin
split
equal
allow
duplic
microarray
pcr
product
speci
combin
purifi
dri
describ
previous
pellet
reconstitut
na
ph
use
reconstitut
dri
pellet
nmol
monoreact
nhydroxysuccinimidyl
ester
amersham
bioscienc
buckinghamshir
uk
incub
dark
hour
rt
dri
dri
dna
label
pellet
reconstitut
nucleas
free
water
ad
hybridis
solut
contain
oligob
alig
technolog
cheshir
uk
filter
sd
filter
ssc
incub
min
denatur
dna
allow
cool
slightli
briefli
centrifug
solut
ad
underneath
coverslip
microarray
slide
humid
hybridis
chamber
camlab
cambridg
uk
incub
overnight
slide
wash
wash
ssc
sd
min
follow
two
wash
wash
b
ssc
min
rt
dri
slide
scan
resolut
pmt
gain
use
confoc
fluoresc
scanner
tecan
salzburg
austria
imag
analys
use
arraypro
analys
version
mediacybernet
softwar
local
background
signal
subtract
refer
sampl
channel
net
intens
fluoresc
signal
sampl
channel
divid
net
intens
control
channel
everi
spot
express
signal
ratio
valu
ratio
consid
posit
ratio
consid
strongli
posit
result
compar
realtim
quantit
pcr
result
specif
pcr
product
probe
assess
hybridis
dilut
plasmid
dna
contain
specif
gene
bacteri
speci
bacteri
target
dna
microarray
check
cross
hybridis
nest
primer
target
specif
function
gene
rang
bacteria
associ
respiratori
infect
use
summar
tabl
quantit
realtim
pcr
sampl
control
clone
standard
carri
use
speci
specif
standard
curv
previous
describ
curran
et
al
proofofconcept
evalu
clinic
specimen
process
fourteen
induc
sputum
sampl
collect
larger
ethic
approv
studi
use
comparison
bacteri
assay
subject
recruit
use
american
thorac
societi
at
criteria
copd
american
thorac
societi
induc
sputum
sampl
obtain
use
previous
publish
method
hargreav
leigh
pavord
et
al
sputum
sampl
process
within
h
collect
homogenis
use
equal
volum
wv
dithiothreitol
sputasol
oxoid
hampshir
uk
homogenis
sputum
volum
phosphat
buffer
salin
pb
incub
shaken
min
filter
remov
cell
debri
spun
min
supernat
discard
sampl
resuspend
sampl
lysi
buffer
buffer
al
qiagen
crawley
uk
preserv
nucleic
acid
sampl
dna
extract
firstli
treat
inhous
lysi
solut
stock
solut
consist
ml
filter
steril
buffer
mm
tri
mm
edta
sigma
triton
mg
lysozym
sigma
pool
uk
u
mutanolysin
sigma
pool
uk
u
lysostaphin
sigma
pool
uk
genom
dna
extract
carri
use
qiagen
dna
blood
kit
qiagen
crawley
uk
accord
manufactur
instruct
specif
pcr
product
probe
individu
evalu
panel
bacteria
found
hybridis
specif
complementari
probe
cross
hybrid
observ
variabl
fluoresc
signal
follow
hybridis
occur
microarray
experi
investig
analysi
fluoresc
signal
oligoa
mix
probe
hybridis
oligob
hybridis
mix
visual
refer
channel
sourc
variat
evalu
examin
distribut
signal
replic
microarray
hybridis
duplic
independ
microarray
hybridis
differ
slide
variat
independ
hybridis
signal
signal
duplic
array
slide
remain
constant
proofofconcept
evalu
valid
microarray
plasmid
dna
criteria
posit
diagnost
hybridis
find
samplerefer
signal
ratio
greater
equal
bacteri
plasmid
dna
use
evalu
perform
probe
buffer
control
redund
probe
detect
nonspecif
hybridis
neg
hybridis
plasmid
dna
bacteri
speci
hybridis
correctli
complementari
probe
microarray
cross
reaction
bacteri
probe
observ
sputa
patient
copd
examin
employ
optimis
microarray
compar
realtim
quantit
pcr
result
sampl
shown
tabl
sputa
contain
least
one
pathogen
rang
four
pathogen
mean
pathogenspati
five
patient
sole
pathogen
nine
patient
polymicrobi
infect
gramposit
well
gramneg
pathogen
detect
common
pathogen
detect
catarrhali
pneumonia
detect
patient
agreement
microarray
realtim
pcr
result
nine
bacteri
speci
detect
everi
sampl
strength
signal
ratio
relat
directli
quantiti
bacteri
speci
detect
realtim
pcr
develop
success
microarray
requir
optimis
number
differ
compon
includ
probe
suitabl
array
surfac
chemistri
print
label
target
dna
hybridis
scan
final
optimis
approach
involv
pcr
product
probe
speci
specif
function
gene
print
onto
epoxyco
slide
indirect
incorpor
fluoresc
dye
label
sampl
dna
inclus
label
refer
dna
indirect
label
utilis
lower
cost
give
brighter
result
avoid
enzymat
bia
speci
specif
probe
evalu
specif
use
individu
hybridis
extract
bacteri
isol
addit
plasmid
contain
speci
specif
target
dna
region
shown
highli
specif
cross
reactiv
final
proofof
concept
evalu
perform
demonstr
employ
array
sputa
specimen
copd
patient
success
detect
sever
pathogen
simultan
result
compar
realtim
pcr
analysi
good
agreement
refer
dna
signal
print
replic
probe
within
hybridis
hybridis
signal
distribut
independ
duplic
microarray
vari
variat
emphasis
import
includ
refer
dna
dual
channel
experi
channel
experi
channel
signal
spot
gener
hybridis
refer
dna
standardis
channel
signal
sampl
hybridis
express
hybridis
ratio
regardless
variat
amount
dna
spot
microarray
spatial
variat
extent
microarray
hybridis
normalis
channel
signal
compar
standardis
necessari
avoid
error
origin
probe
concentr
spatial
variat
hybridis
effici
addit
much
replic
possibl
includ
within
microarray
also
term
number
individu
slide
use
per
sampl
use
autom
hybridis
station
would
benefici
would
allow
closer
control
hybridis
temperatur
hybridis
agit
highli
reproduc
wash
grimm
et
al
although
microarray
detect
low
level
dna
product
amplif
characterist
diagnost
sequenc
prior
hybridis
microarray
requir
produc
suffici
signal
organ
detect
futur
develop
respiratori
microarray
would
ideal
allow
addit
probe
target
addit
bacteri
speci
virus
fungi
antimicrobi
resist
gene
multiplex
amplif
approach
addit
microarray
offer
obviou
advantag
simultan
amplif
detect
clinic
specimen
complex
flora
overal
number
divers
target
organ
design
array
tailor
specif
diseas
state
cystic
fibrosi
conclus
data
describ
novel
respiratori
microarray
use
pcr
product
probe
detect
nine
bacteri
speci
human
respiratori
tract
techniqu
potenti
use
method
monitor
popul
bacteria
respiratori
sampl
microarray
offer
advantag
unlimit
target
detect
simultan
detect
organ
clinic
specimen
complex
flora
futur
work
allow
addit
target
ad
microarray
platform
larger
clinic
evalu
